glp 1 ra drugs GLP-1 Drug Comparison in Diabetes and Obesity Treatment Evolution of GLP‐1 Receptor Agonists

Clinical trials have shown that GLP-1R agonists increase microvascular blood volume and flow in cardiac muscle, and these effects are preserved in obese individuals with vascular insulin resistance

[30] Exenatide was approved by the FDA in April 2005, for people whose diabetes is not well controlled on other oral medications

Dose conversion considerations There is no perfect dose equivalence between different GLP-1 medications because they work through different receptor combinations and have different potencies

A polygenic integrative analysis has provided evidence that STAT function is significantly dysregulated in the ovary in PCOS (203)

Mack CM, Soares CJ, Wilson JK, Athanacio JR, Turek VF, Trevaskis JL, Roth JD, Smith PA, Gedulin B, Jodka CM, Roland BL, Adams SH, Lwin A, Herich J, Laugero KD, Vu C, Pittner R, Jr JRP

The third action, which I think is also critical, is it causes a person to feel full